Trade

with

Opko Health Inc
(NYSE: OPK)
AdChoices
8.22
-0.17
-2.03%
Pre-Market :
8.20
-0.02
-0.24%

Open

8.39

Previous Close

8.39

Volume (Avg)

2.28M (2.29M)

Day's Range

8.20-8.39

52Wk Range

7.32-11.64

Market Cap.

3.53B

Dividend Rate ( Yield )

-

Beta

0.99

Shares Outstanding

429.20M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 96.53M

    • Net Income

    • -114.41M

    • Market Cap.

    • 3.53B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -168.47

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.99

    • Forward P/E

    • -28.33

    • Price/Sales

    • 37.59

    • Price/Book Value

    • 3.85

    • Price/Cash flow

    • -39.53

      • EBITDA

      • -75.20M

      • Return on Capital %

      • -14.92

      • Return on Equity %

      • -23.84

      • Return on Assets %

      • -14.92

      • Book Value/Share

      • 2.14

      • Shares Outstanding

      • 429.20M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 11.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -0.30

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -1.20

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 59.20

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 43.83

            • 64.08

            • Pre-Tax Margin

            • -161.05

            • 15.19

            • Net Profit Margin

            • -168.47

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 40.00

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -110.30

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -98.50

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.13

              • 0.34

              • Current Ratio

              • 2.30

              • 2.55

              • Quick Ratio

              • 2.00

              • 1.83

              • Interest Coverage

              • -8.21

              • 11.70

              • Leverage Ratio

              • 1.45

              • 1.86

              • Book Value/Share

              • 2.14

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -22.83

                • 34.72

                • P/E Ratio 5-Year High

                • -35.21

                • 224.03

                • P/E Ratio 5-Year Low

                • -4.08

                • 60.23

                • Price/Sales Ratio

                • 38.46

                • 3.22

                • Price/Book Value

                • 3.92

                • 3.26

                • Price/Cash Flow Ratio

                • -39.53

                • 18.80

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -23.84

                        (-40.80)

                      • 12.33

                        (18.16)

                      • Return on Assets %

                        (5-Year Average)

                      • -14.92

                        (-22.20)

                      • 6.62

                        (8.69)

                      • Return on Capital %

                        (5-Year Average)

                      • -16.80

                        (-28.30)

                      • 8.49

                        (11.48)

                      • Income/Employee

                      • -

                      • 34.11k

                      • Inventory Turnover

                      • 2.57

                      • 2.77

                      • Asset Turnover

                      • 0.09

                      • 0.51

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -79.63M
                      Operating Margin
                      -82.49
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -39.53
                      Ownership

                      Institutional Ownership

                      94.31%

                      Top 10 Institutions

                      97.68%

                      Mutual Fund Ownership

                      8.92%

                      Float

                      53.77%

                      5% / Insider Ownership

                      8.07%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Fidelity® Select Biotechnology Portfolio

                      •  

                        3,676,509

                      • 0.00

                      • 0.86

                      • Vanguard Small Cap Index

                      •  

                        3,583,069

                      • -0.64

                      • 0.83

                      • Vanguard Total Stock Mkt Idx

                      •  

                        3,419,265

                      • 0.13

                      • 0.80

                      • iShares Russell 2000 (AU)

                      •  

                        3,033,275

                      • -0.90

                      • 0.70

                      • Vanguard Small Cap Growth Index Fund

                      •  

                        2,421,836

                      • -2.53

                      • 0.56

                      • Vanguard Extended Market Index Fund

                      •  

                        2,091,812

                      • 2.37

                      • 0.49

                      • SPDR® S&P Biotech ETF

                      •  

                        2,061,279

                      • 0.00

                      • 0.47

                      • Fidelity® Contrafund® Fund

                      •  

                        1,430,900

                      • 0.00

                      • 0.33

                      • iShares Russell 2000 Growth

                      •  

                        1,398,851

                      • -0.45

                      • 0.32

                      • Fidelity Advisor® Biotechnology Fund

                      •  

                        791,951

                      • 0.00

                      • 0.18

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Frost Gamma Investments Trust

                      •  

                        155,608,105

                      • +58.61%

                      • 37.67

                      • Frost Phillip MD Et AL

                      •  

                        155,060,635

                      • +16.43%

                      • 46.04

                      • Frost Group LLC

                      •  

                        15,490,546

                      • 0.00%

                      • 3.75

                      • Vanguard Group, Inc.

                      •  

                        12,673,310

                      • -0.37%

                      • 2.98

                      • Orchard Hill Capital Management LLC

                      •  

                        7,326,900

                      • +1,489.35%

                      • 1.72

                      • BlackRock Fund Advisors

                      •  

                        5,754,634

                      • -0.46%

                      • 1.35

                      • Oracle Investment Management Inc

                      •  

                        5,655,738

                      • +1.50%

                      • 1.33

                      • State Street Corp

                      •  

                        4,851,827

                      • -5.39%

                      • 1.14

                      • Fidelity Management and Research Company

                      •  

                        4,468,460

                      • -7.45%

                      • 1.05

                      • Menora Mivtachim Life Insurance

                      •  

                        2,773,085

                      • +4.50%

                      • 0.65

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Devices

                      Type

                      Distressed

                      Style

                      Small Growth

                      Opko Health Inc was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics, Inc. The Company is a multi-national biopharmaceutical and diagnostics company. It is developing various solutions to di...moreagnose, treat and prevent various conditions, including point-of-care tests, laboratory developed tests, molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It owns established pharmaceutical platforms in Chile, Spain, Mexico and Uruguay. It also has established pharmaceutical operations in Brazil. The Company owns a specialty active pharmaceutical ingredients manufacturer in Israel. The Company currently manages its operations in two reportable segments, pharmaceutical and diagnostics. The pharmaceutical segment consists of two operating segments,...more its (i) pharmaceutical research and development segment which is focused on the research and development of pharmaceutical products and vaccines, and (ii) the pharmaceutical operations it acquired in Chile, Spain, Mexico, Israel, Spain, Uruguay and Brazil. The diagnostics segment consists of two operating segments, the Companys (i) pathology operations it acquired through the acquisition of OPKO Lab and (ii) point-of-care and molecular diagnostics operations. Its main products Rayaldy and Alpharen are in phase 3 clinical development. Its competitors include diagnostic companies, reference laboratories, molecular diagnostic firms, universities and research institutions. The testing, manufacture, distribution, advertising, and marketing of drug and diagnostic products and medical devices are subject to extensive regulation by federal, state, and local governmental authorities in the U.S., including the FDA, and by similar agencies in other countries.lessless

                      Key People

                      Dr. Phillip Frost,M.D.

                      CEO/Chairman of the Board/Director

                      Dr. Arie Gutman

                      CEO, Divisional

                      Mr. Charles W Bishop, Pd.D

                      CEO, Subsidiary

                      Dr. Jane H. Hsiao, PhD

                      Chief Technology Officer/Director/Vice Chairman of the Board

                      Adam E. Logal

                      CFO/Senior VP

                      • Opko Health Inc

                      • 4400 Biscayne Boulevard

                      • Miami, FL 33137

                      • USA.Map

                      • Phone: +1 305 575-4100

                      • Fax: -

                      • opko.com

                      Incorporated

                      1991

                      Employees

                      625

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: